These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23707333)

  • 1. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
    Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
    J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acacetin blocks kv1.3 channels and inhibits human T cell activation.
    Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH
    Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels.
    Du YM; Xia CK; Zhao N; Dong Q; Lei M; Xia JH
    Acta Pharmacol Sin; 2012 Jun; 33(6):752-60. PubMed ID: 22609834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties.
    Zhao N; Dong Q; Qian C; Li S; Wu QF; Ding D; Li J; Wang BB; Guo KF; Xie JJ; Cheng X; Liao YH; Du YM
    Sci Rep; 2015 Nov; 5():17381. PubMed ID: 26616555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrretinic acid blocks cardiac sodium channels expressed in Xenopus oocytes.
    Du Y; Zhang S; Wu H; Zou A; Lei M; Cheng L; Liao Y
    J Ethnopharmacol; 2009 Sep; 125(2):318-23. PubMed ID: 19559778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells.
    Zhao N; Dong Q; Du LL; Fu XX; Du YM; Liao YH
    PLoS One; 2013; 8(5):e64629. PubMed ID: 23717641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
    Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
    J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions.
    Wang CY; Kao TC; Lo WH; Yen GC
    J Agric Food Chem; 2011 Jul; 59(14):7726-33. PubMed ID: 21644799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.
    Villalonga N; David M; Bielańska J; González T; Parra D; Soler C; Comes N; Valenzuela C; Felipe A
    Biochem Pharmacol; 2010 Sep; 80(6):858-66. PubMed ID: 20488163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxin mimic FS48 from the salivary gland of Xenopsylla cheopis functions as a Kv1.3 channel-blocking immunomodulator of T cell activation.
    Zeng Q; Lu W; Deng Z; Zhang B; Wu J; Chai J; Chen X; Xu X
    J Biol Chem; 2022 Jan; 298(1):101497. PubMed ID: 34919963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18β-glycyrrhetinic acid induces immunological adjuvant activity of Th1 against Candida albicans surface mannan extract.
    Kim J; Joo I; Kim H; Han Y
    Phytomedicine; 2013 Aug; 20(11):951-5. PubMed ID: 23746951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity.
    Park M; Lee JH; Choi JK; Hong YD; Bae IH; Lim KM; Park YH; Ha H
    Mol Nutr Food Res; 2014 Jul; 58(7):1436-46. PubMed ID: 24687644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licorice metabolite 18β-glycyrrhetinic acid activates G protein-gated inwardly rectifying K
    Chen IS; Yasuda J; Notomi T; Nakamura TY
    Br J Pharmacol; 2024 Feb; 181(3):447-463. PubMed ID: 37642133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms for Kv1.3 potassium channel current inhibition by CD3/CD28 stimulation in Jurkat T cells.
    Matsushita Y; Ohya S; Itoda H; Kimura T; Suzuki Y; Yamamura H; Imaizumi Y
    Biochem Biophys Res Commun; 2008 Sep; 374(1):152-7. PubMed ID: 18611390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of 6-Prenylnaringenin and Selected Non-prenylated Flavonoids on the Activity of Kv1.3 Channels in Human Jurkat T Cells.
    Teisseyre A; Palko-Labuz A; Uryga A; Michalak K
    J Membr Biol; 2018 Dec; 251(5-6):695-704. PubMed ID: 30187077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18ß-glycyrrhetinic acid derivative promotes proliferation, migration and aquaporin-3 expression in human dermal fibroblasts.
    Hung CF; Hsiao CY; Hsieh WH; Li HJ; Tsai YJ; Lin CN; Chang HH; Wu NL
    PLoS One; 2017; 12(8):e0182981. PubMed ID: 28813533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 18β-glycyrrhetinic acid and hydroxypropyl γcyclodextrin complex on indomethacin-induced small intestinal injury in mice.
    Ishida T; Miki I; Tanahashi T; Yagi S; Kondo Y; Inoue J; Kawauchi S; Nishiumi S; Yoshida M; Maeda H; Tode C; Takeuchi A; Nakayama H; Azuma T; Mizuno S
    Eur J Pharmacol; 2013 Aug; 714(1-3):125-31. PubMed ID: 23792039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin inhibits Jurkat T-cell activation by blocking calcium entry current I(CRAC).
    Fischer BS; Qin D; Kim K; McDonald TV
    J Pharmacol Exp Ther; 2001 Oct; 299(1):238-46. PubMed ID: 11561085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.